Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.27165 | 10 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.24502 | 10 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.24039 | 10 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.20083 | 10 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.18976 | 9 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.30615 | 10 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.26147 | 10 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.22388 | 10 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.22976 | 10 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.23481 | 10 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.24708 | 10 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.21836 | 10 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.1699 | 8 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.23598 | 10 |